News | Defibrillator Monitors | January 13, 2020

LifePAK 15 Defibrillators Might Fail After Shock Button is Pressed

Stryker launches voluntary field action for some LifePAK units 

tryker is launching a voluntary field action on specific units of the LifePAK 15 defibrillator/monitors. The vendor said an issue has been identified where the devices to fail to deliver a defibrillation shock after the “Shock” button on the keypad is pressed.

tryker is launching a voluntary field action on specific units of the LifePAK 15 defibrillator/monitors. The vendor said an issue has been identified where the devices to fail to deliver a defibrillation shock after the “Shock” button on the keypad is pressed.


January 13, 2020 — Stryker announced it is launching a voluntary field action on specific units of the LifePAK 15 defibrillator/monitors. The vendor said an issue has been identified where the devices fail to deliver a defibrillation shock after the “Shock” button on the keypad is pressed. This is a result of oxidation that may have formed over time within the button.

The company is contacting customers with impacted devices to schedule the correction of their device(s), which will include replacement of the affected keypad. Stryker anticipates that all devices subject to this field action will be serviced by June 2021. The company began contacting customers about the issue Dec. 27, 2019. EImpacted customers will be notified by letter and will be requested to verify their device status, Stryker said.

Most complaints associated with this issue were detected prior to patient use. Routine testing of the device can detect this fault condition, the company said. 

The company is instructing customers to continue to use their LifePAK 15 monitor/defibrillator according to the operating instructions until the correction can be completed. Customers should continue to perform the daily check as described in the operator’s checklist, specifically, the Quik-Combo therapy cable check as described in the general maintenance and testing section (pages 10-4 and the LifePAK 15 monitor/defibrillator operator’s checklist, number 7).

If a customer experiences this issue, they should contact Stryker as soon as possible at 1-800-787-9537 and select option 2.

Customers with questions regarding this notification, please contact Stryker by calling 1-800-787-9537, option 2, 8 a.m. to 7 p.m. (EST), Monday – Friday, or by e-mail to [email protected] or 1-800- 329-7879.

In addition to contacting Stryker, any potential quality problems or adverse reactions or events associated with the use of a product from Stryker may be reported online to the U. S. Food and Drug Administration’s MedWatch Safety Information and Adverse Event Reporting Program at www.fda.gov/safety/medwatch, by phone 1-800-332-1088.

Read the FDA recall notice: www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/stryker-launches-voluntary-field-action-specific-units-lifepakr-15-monitordefibrillator

Link to the Stryker product notice: www.strykeremergencycare.com/productnotices

The company issued a previous recall for the LiefPAK 15 in February 2019 for a different issue. Read the article "Stryker Warns LifePak15 Defibrillators May Lock Up After Shock is Delivered."

 

 

Related Content

Feature | Cardiac Diagnostics | By Adam Saltman, MD, PhD

Before opining on the future of cardiac health, I think it’s important to define what “cardiac health” actually is. If ...

Home May 04, 2022
Home
News | Cardiac Diagnostics

January 31, 2022 — Scientists have developed an artificial intelligence (AI) system that can analyze eye scans taken ...

Home January 31, 2022
Home
News | Cardiac Diagnostics

November 10, 2021 — Abbott released new global market research from its Beyond Intervention initiative, the company’s ...

Home November 10, 2021
Home
Feature | Cardiac Diagnostics | By Dave Fornell, DAIC Editor

October 29, 2021 — A new guideline for the evaluation and diagnosis of chest pain was released this week that provides ...

Home October 29, 2021
Home
News | Cardiac Diagnostics

October 4, 2021 – Nanowear, a hospital-at-home and remote diagnostic platform that used proprietary wearable cloth ...

Home October 04, 2021
Home
News | Cardiac Diagnostics

September 28, 2021 — Biotricity Inc., a medical diagnostic and consumer healthcare technology company, has developed a ...

Home September 28, 2021
Home
News | Cardiac Diagnostics

July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation ...

Home July 29, 2021
Home
News | Cardiac Diagnostics

July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc. second-generation ...

Home July 01, 2021
Home
News | Cardiac Diagnostics

March 8, 2021 — In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a potential ...

Home March 08, 2021
Home
News | Cardiac Diagnostics

March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management ...

Home March 03, 2021
Home
Subscribe Now